Form 4 for RMD ResMed|
Accepted 2024-11-12 00:00:00 ET · period of report 2024-11-11 · accession 0001127602-24-027070 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-11-12 | 2024-11-11 | RMD | Ghoshal Kaushik | Chief Commercial Off, SaaS | F - Tax | $252.38 | -2,467 | 11.6K | -18% | -$622.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | ResMed Common Stock | 2024-11-11 | F | D | 1,417.93 | $252.38 | 9,725 | D | — | — | |
| 2 | Common | ResMed Common Stock | 2024-11-11 | F | D | 445.59 | $252.38 | 11,142 | D | — | — | |
| 3 | Common | ResMed Common Stock | 2024-11-11 | F | D | 603.08 | $252.38 | 11,588 | D | — | — |